Author

Vladimer Getia

Observed names: Getia, Vladimer, V Getia, V. Getia, Vladimer Khvicha Getia, Vladimir Getia

Institution: National Center for Disease Control and Public Health

Observed institutions: National Center for Disease Control and Public Health, University of Palermo, University of Palermo

ORCID: 0000-0001-9337-1908

Observed ORCID: 0000-0001-9337-1908

OpenAlex ID: A5000745962

Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia

2019 · Francisco Averhoff, Shaun Shadaker, et al. · Journal of Hepatology · 61

Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015–April 2024

2024 · Rania A. Tohme, Shaun Shadaker, et al. · MMWR Morbidity and Mortality Weekly Report · 23

Screening and linkage to care for hepatitis C among inpatients in Georgia's national hospital screening program

2020 · Shaun Shadaker, Muazzam Nasrullah, et al. · Preventive Medicine · 16

Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program

2020 · Evan M. Bloch, Eteri Kipiani, et al. · Transfusion · 15

The impact of COVID-19 pandemic on the 2020 hepatitis C cascade of care in the Republic of Georgia

2022 · A. Gamkrelidze, S. Handanagic, et al. · Public Health · 12

Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines)

2024 · Megan A Hansen, Nkgomeleng A Lekodeba, et al. · BMJ Open · 9

PDF

Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia

2021 · Ketevan Stvilia, Nino Vephkvadze, et al. · Public Health · 9

Reduction in Blood Lead Concentration in Children across the Republic of Georgia following Interventions to Address Widespread Exceedance of Reference Value in 2019

2021 · Ekaterine Ruadze, Giovanni S. Leonardi, et al. · International Journal of Environmental Research and Public Health · 8

PDF

Implementing a pilot study of COVID-19 self-testing in high-risk populations and remote locations: results and lessons learnt

2024 · Elena Marbán-Castro, Vladimer Getia, et al. · BMC Public Health · 7

PDF

Hepatitis C virus attributable liver cancer in the country of Georgia, 2015–2019: a case–control study

2024 · Sophia Surguladze, Paige A. Armstrong, et al. · BMC Infectious Diseases · 6

PDF

Advancing blood transfusion safety using molecular detection in the country of Georgia

2023 · Maia Alkhazashvili, Evan M. Bloch, et al. · Transfusion Clinique et Biologique · 6

PDF

Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017

2022 · Irina Tskhomelidze, Shaun Shadaker, et al. · Liver International · 5

PDF

Trends in new hepatitis C virus infections among repeat blood donors – Georgia, 2017–2023

2024 · Shaun Shadaker, Davit Baliashvili, et al. · Transfusion Clinique et Biologique · 3

Epidemiology and transmission of COVID-19 in cases and close contacts in Georgia in the first four months of the epidemic

2021 · Josephine G. Walker, Irine Tskhomelidze, et al. · medRxiv · 2

PDF

PS-071-Piloting of integrated HCV, TB and HIV screening model at primary care level in Georgia

2019 · Irma Khonelidze, Amiran Gamkrelidze, et al. · Journal of Hepatology · 2

Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia

2026 · Josephine G. Walker, Irina Tskhomelidze Schumacher, et al. · PLOS Global Public Health · 1

PDF

Prevalence of transfusion transmitted infections by mode of donation and remuneration status among blood donors in Georgia, 2018–2023

2025 · Ketevan Shermadini, Evan M. Bloch, et al. · Transfusion and Apheresis Science · 1

Blood transfusion service in Georgia

2023 · Ketevan Shermadini, Maia Alkhazashvili, et al. · Transfusion and Apheresis Science · 1

Innovative linkage model to re-engage loss-to-follow-up individuals in the national hepatitis C elimination program of Georgia

2022 · Amiran Gamkrelidze, Alexander Turdziladze, et al. · Journal of Hepatology · 1

Progress in hepatitis C testing as a part of the hepatitis C elimination program in Georgia

2020 · Amiran Gamkrelidze, Tamar Gabunia, et al. · Journal of Hepatology · 1

PDF

THU-396-Hepatitis C screening among the population of Georgia within the national elimination program

2019 · David Sergeenko, Maia Lagvilava, et al. · Journal of Hepatology · 1

Hepatitis C screening within the national elimination program in the country of Georgia

2018 · A. Gamkrelidze, A. Turdziladze, et al. · Journal of Hepatology · 1

Incidence of and Risk Factors for Tuberculosis Among Patients Treated for Hepatitis C: a Population-based Cohort Study

2026 · Tamta Korinteli, Nestani Tukvadze, et al. · Open Forum Infectious Diseases

Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022

2026 · Anna Khoperia, Susan H. Gawel, et al. · PLoS ONE

Identifying and Linking to Care and Treatment Persons With Hepatitis C Who Were Lost to Follow‐Up, Georgia 2023–2024

2026 · Vladimer Getia, Paata Imnadze, et al. · Journal of Viral Hepatitis

Works count: 44

Citation count: 191

H-index: 8

I10-index: 5